CURIS, INC. Debt Securities, Available-for-sale, Unrealized Loss Position
CURIS, INC. (CRIS) had Debt Securities, Available-for-sale, Unrealized Loss Position of $0 as of 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Notes › Investments
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2020-11-10
- 2020-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $0.00.
- 2020-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $0.00.
- 2020-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $0.00.
- 2019-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $0.00.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-04 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-12 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-05 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-14 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |